Merck KGaA acquires Taiho's UFT

Merck KGaA (FSE:MRK) acquired global rights to colorectal cancer chemotherapuetic UFT tegafur/uracil from Taiho (Tokyo, Japan). The deal excludes Japan, South Korea, Taiwan, Malaysia and Singapore. Ea...